EMMA MASHBURN: Open Payments
NPI 1679283386 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 36 payments from 7 companies in 2025. Trend: 2023 $13 · 2024 $419 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $467 |
| Gilead Sciences, Inc. | 3 | $64 |
| Corcept Therapeutics | 2 | $42 |
| Sonex Health, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
Products named: QULIPTA, VRAYLAR, UBRELVY, Korlym, SX-ONE MICROKNIFE, NURTEC ODT, CAPLYTA, MOUNJARO.
Industry payments across TN — which companies pay providers there.
